Yanling Ren (Yanlin Ren)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Venues

Hematological oncology

Science advances

Cancer medicine

SAGE open medical case reports

Zhejiang University School of Medicine First Affiliated Hospital

Zhejiang University First Affiliated Hospital Department of Hematology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Zhejiang University School of Medicine First Affiliated Hospital Sep 01 2014

China

Fellow :: Hematology

Education History

Zhejiang University First Affiliated Hospital Department of Hematology Aug 01 2006 - Jun 30 2008

China

PHD :: Hematology

Publications

Shuanghong Zhu, Yingwan Luo, Kongfei Li, Chen Mei, Yuxia Wang, Lingxu Jiang, Wei Wang, Qi Zhang, Wenli Yang, Wei Lang, Xinping Zhou, Lu Wang, Yanling Ren, Liya Ma, Li Ye, Xin Huang, Jianjun Chen, Jie Sun, Hong-Yan Tong
RIPK3 deficiency blocks R-2-hydroxyglutarate-induced necroptosis in IDH-mutated AML cells. Science advances 10 (16) (2024)
Xianbo Huang, Xianhui Wu, Shasha Wang, Chen Mei, Yu Xu, Yanling Ren, Jie Jin, Hong-Yan Tong, Jiejing Qian
Effective management of a rare case of primary renal intravascular large B-cell lymphoma with modified R-CHOP regimen: A case report. SAGE open medical case reports 12 (2024)
Shuanghong Zhu, Yingwan Luo, Kongfei Li, Chen Mei, Yuxia Wang, Lingxu Jiang, Wei Wang, Qi Zhang, Wenli Yang, Wei Lang, Xinping Zhou, Lu Wang, Yanling Ren, Liya Ma, Li Ye, Xin Huang, Jianjun Chen, Jie Sun, Hong-Yan Tong
RIPK3 deficiency blocks R-2-hydroxyglutarate-induced necroptosis in IDH-mutated AML cells. Science advances 10 (16) (2024)
Xianbo Huang, Xianhui Wu, Shasha Wang, Chen Mei, Yu Xu, Yanling Ren, Jie Jin, Hong-Yan Tong, Jiejing Qian
Effective management of a rare case of primary renal intravascular large B-cell lymphoma with modified R-CHOP regimen: A case report. SAGE open medical case reports 12 (2024)
Yanling Ren, Wei Lang, Chen Mei, Yingwan Luo, Li Ye, Lu Wang, Xinping Zhou, Gaixiang Xu, Liya Ma, Jie Jin, Hongyan Tong
Co-mutation landscape and clinical significance of RAS pathway related gene mutations in patients with myelodysplastic syndrome. Hematological oncology (2022)
Chen Mei, Li Ye, Yanling Ren, Xinping Zhou, Liya Ma, Gaixiang Xu, Weilai Xu, Chenxi Lu, Haiyang Yang, Yingwan Luo, Lingxu Jiang, Wei Lang, HongHu Zhu, Jie Jin, Hongyan Tong
15-days duration of venetoclax combined with azacitidine in the treatment of relapsed/refractory high-risk myelodysplastic syndromes: A retrospective single-center study. Hematological oncology (2022)
Chen Mei, Li Ye, Yanling Ren, Xinping Zhou, Liya Ma, Gaixiang Xu, Weilai Xu, Chenxi Lu, Haiyang Yang, Yingwan Luo, Lingxu Jiang, Wei Lang, HongHu Zhu, Jie Jin, Hongyan Tong
15-days duration of Venetoclax combined with azacitidine in the treatment of relapsed/refractory high-risk myelodysplastic syndromes: A retrospective single-center study. Hematological oncology (2022)
Xuefen Yan, Lu Wang, Lingxu Jiang, Yingwan Luo, Peipei Lin, Wenli Yang, Yanling Ren, Liya Ma, Xinping Zhou, Chen Mei, Li Ye, Gaixiang Xu, Weilai Xu, Haiyang Yang, Chenxi Lu, Jie Jin, Hong-Yan Tong
Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes. Cancer medicine 10 (5) (2021)
Liya Ma, Lingxu Jiang, Wenli Yang, Yingwan Luo, Chen Mei, Xinping Zhou, Gaixiang Xu, Weilai Xu, Li Ye, Yanling Ren, Chenxi Lu, Peipei Lin, Jie Jin, Hong-Yan Tong
Real-world data of chronic myelomonocytic leukemia: A chinese single-center retrospective study. Cancer medicine 10 (5) (2021)
Xinping Zhou, Chen Mei, Jin Zhang, Ying Lu, Jianping Lan, Shengyun Lin, Yuefeng Zhang, Yuemin Kuang, Yanling Ren, Liya Ma, Juying Wei, Li Ye, Weilai Xu, Kongfei Li, Chenxi Lu, Jie Jin, Hongyan Tong
Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher-risk myelodysplastic syndromes: a prospective multicenter single-arm trial. Hematological oncology 38 (4) (2020)
Yanling Ren, Jinghan Wang, Hua Zhang, Chen Mei, Li Ye, Yingwan Luo, Xinping Zhou, Shuanghong Zhu, Lingxu Jiang, Lu Wang, Jie Jin, Hongyan Tong
TP53 mutations are associated with very complex karyotype and suggest poor prognosis in newly diagnosed myelodysplastic syndrome patients with monosomal karyotype. Asia-Pacific journal of clinical oncology 16 (3) (2020)

Yanling Ren.css-eqlu8i{font-size:small;padding-left:4px;} (Yanlin Ren)

Publication Activity (10 Years)

Top Topics

Top Venues

Yanling Ren (Yanlin Ren)